eli lilly phase 3 trial retatrutide said Thursday its experimental obesity drug delivered up to 28.3 percent body-weight reduction over 80 weeks in the pivotal TRIUMPH-1 trial, a result nearing the weight-loss range Lilly's triple agonist, retatrutide, delivered
Description
doi: 10.1111/dom.12872 8 SunFChaiSYuKQuanXYangZWuSet al
An estimated 5075% of users discontinue within their first year, according to research cited by Northwestern University in November 2024
Myers, M
MeAgain is built for that with a shot log, body diagram, 0-to-10 side effect tracking, meal logging, the medication graph, and the Capybara home screen widget
That means smaller injection volumes and better comfort, but it also means each unit on your syringe carries more weight
Manufacturer savings programs Eli Lilly has not yet launched retatrutide commercially, so no manufacturer savings program currently exists
